Copyright
©The Author(s) 2021.
World J Gastroenterol. Jan 28, 2021; 27(4): 336-344
Published online Jan 28, 2021. doi: 10.3748/wjg.v27.i4.336
Published online Jan 28, 2021. doi: 10.3748/wjg.v27.i4.336
Table 2 Comparison of histopathological characteristics between metabolic associated fatty liver disease and hepatitis B virus-metabolic associated fatty liver disease groups
| Inflammatory stage | Fibrosis stage | Steatosis stage | |||||||||||
| 0 | 1 | 2 | 3 | 4 | 0 | 1 | 2 | 3 | 4 | 1 | 2 | 3 | |
| MAFLD; n (%) | 2 (3.4) | 36 (62.2) | 9 (15.5) | 9 (15.5) | 2 (3.4) | 15 (25.9) | 23 (39.7) | 11 (19.0) | 7 (12.0) | 2 (3.4) | 11 (18.9) | 15 (25.9) | 32 (55.2) |
| HBV-MAFLD; n (%) | 0 (0) | 16 (27.6) | 15 (25.9) | 18 (31.0) | 9 (15.5) | 3 (5.2) | 15 (25.9) | 17 (29.3) | 14 (24.1) | 9 (15.5) | 37 (63.8) | 11 (19.0) | 10 (17.2) |
| Z | -4.193 | -4.131 | -5.060 | ||||||||||
| P value | < 0.001 | < 0.001 | < 0.001 | ||||||||||
- Citation: Wang MF, Wan B, Wu YL, Huang JF, Zhu YY, Li YB. Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection. World J Gastroenterol 2021; 27(4): 336-344
- URL: https://www.wjgnet.com/1007-9327/full/v27/i4/336.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i4.336